3D Tissue Models

This person is not registered. Is this you?


Profile Details
Markus Schwaiger
Affiliations:

Technical University of Munich

 
,
Phone:
Fax:
My Blogs:
My Twitter Hashtags:
@M_Schwaiger
 
Age:
Bio:
 
Specialty:
Cancer Immunotherapy
 
Presented at Events Covering:
, Cancer Biology, Oncology
 
Areas of Interest:
 
Hobbies:
 
General Comments:
BSN Rank: 12897 / 3501 (What's this?)
Accomplish Score: 13
Popularity Score: Unavailable
# in My Circle: 0
# in My Org(s): 12
We'll Post Your CV for Free!
 
 
Speaking/Presenting-Abstract/Poster at Mtg: 1 (13 / 0)
 
Honors and Awards: 0 (0 / 0)
 
Clinical Trial Activity: 0 (0 / 0)
 
Grant Support: 0 (0 / 0)
 
Patents Pending: 0 (0 / 0)
 
Journal - Editor/Reviewer: 0 (0 / 0)
 
Peer Reviewed Papers, Books, Chapters: 7 (42 / 0)
  • A number of different technologies have been developed to monitor in vivo the distribution of gene-modified T cells used in immunotherapy. ()
  • Integrins are key regulators of communication between cells and with their microenvironment. ()
  • Purpose: Based on the clinical relevance of the chemokine receptor 4 (CXCR4) as a molecular target in cancer and on the success of [68Ga]pentixafor as an imaging probe for high-contrast visualization of CXCR4-expression, the spectrum of clinical CXCR4-targeting was expanded towards peptide receptor radionuclide therapy (PRRT) by the development of [177Lu]pentixather. ()
 
Pre/Non Reviewed Papers, Proceedings: 0 (0 / 0)
 
Membership in Professional Societies: 0 (0 / 0)
 
White Papers: 0 (0 / 0)
 
Registered on BiotechScienceNews: 0

About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.